SGS proderm conducts an average of about 600 clinical trials every year. Most of these studies are in vivo investigations with healthy volunteers or patients with different skin diseases. With regard to the recruitment of study participants, one topic is currently very present: the integration of multi-ethnic groups.
Depending on the study specifications and requirements, recruiting such a panel can be very challenging. Based on our dedicated recruitment strategy and our cooperation with colleagues from SGS Institut Fresenius GmbH, we have now doubled the capabilities in enrolling multi-ethnic panels.
SGSproderm
Stephan Bielfeldt
Director Research
ajourden@proderm.de
Less than a month after NYSCC Supplier's Day, Skinobs is thrilled to announce that…
The interplay between the skin microbiome and its host is a complex facet of dermatological…
A group of researchers from China have identified Insulin-like Growth Factor 2 (IGF2) in oral…